RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-5401
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_0922200; Gene model (P.falciparum): PF3D7_1126100; Gene product: autophagy-related protein 7, putative (Atg7)
Details mutation: The mutant contains a FRTed ORF of the Atg7 locus
Details conditional mutagenesis: The ORF of Atg7 is removed in the sporozoite stage by the Flp/FRT system
Transgene
Transgene not Plasmodium: FlpL recombinase of yeast (FlpL)
Promoter: Gene model: PBANKA_1349800; Gene model (P.falciparum): PF3D7_1335900; Gene product: thrombospondin-related anonymous protein | sporozoite surface protein 2 (TRAP; SSP2; SSP-2)
3'UTR: Gene model: PBANKA_1349800; Gene product: sporozoite surface protein 2 thrombospondin-related anonymous protein (sporozoite surface protein 2; SSP2; SSP-2)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Sporozoite; Liver stage;
Last modified: 5 March 2024, 22:21
  *RMgm-5401
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Introduction of a transgene
Reference (PubMed-PMID number) Not published (yet)
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone RMgm-4186
Other information parent lineThis mutant (line 1809) expresses FlpL recombinase under the control of the TRAP promoter, active in the mosquito oocyst stage, and selectively excises the DNA sequence flanked by FRT sites. This mutant does not contain a selectable marker. The flpl gene is integrated into the silent 230p locus by double cross-over integration (by GIMO transfection using line 1596cl1; RMgm-687). The line has been generated in Leiden and cloned in the Sinnis lab.
The mutant parasite was generated by
Name PI/ResearcherMishra A, Mishra S
Name Group/DepartmentDivision of Molecular Microbiology and Immunology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-5401
Principal nameAtg7-cKO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteTo check the excision efficiency of the Atg7 gene in sporozoites, genotyping was performed, which revealed successful excision of the flirted Atg7 locus transfected in the TRAP/FlpL line. These results suggest that Atg7 is not required for the progression of sporozoites from the midgut to the salivary gland.
Liver stageAll mice inoculated with wildtype sporozoites became patent on day 3 p.i., whereas parasites lacking Atg7 (Atg7cKO) failed to initiate blood-stage infection.
Comparable parasite burden in livers in mice infected with Atg7 cKO and wildtype sporozoites until 38 hours post infection (hpi), which which was decreased in late time point samples harvested at 55 hpi. In culture Atg7 cKO sporozoites invaded hepatocytes normally. Immunofluorescence analysis of exo-erythrocytic forms (EEFs) with Hsp70 and UIS4 antibodies followed by quantification revealed normal development until 24 hpi. However, EEFs harvested at 40, 55 and 64 hpi showed arrested growth and a reduction in size and number. A strong defect in nuclear division in Atg7 cKO parasites.
Additional remarks phenotype

Mutant/mutation
The mutant is a 'Flp/FRT conditional knock-out mutant' of Atg7. The mutant expresses the yeast FlpL recombinase under the control of the trap promoter  and contains a FRTed (part of the) ORF (open reading frame) of the Atg locus. 

This mutant has been generated by replacement of the endogenous Atg7 gene by an Atg7 gene with a FRTed ORF in mutant RMgm-4186 that expresses FlpL. This mutant expresses the yeast FlpL recombinase under the control of the promoter of trap and does not contain a selectable marker. The flpl gene is integrated into the silent 230p locus by double cross-over integration.

(Part of)The Atg7 ORF is removed from the genome by using the Flp/FRT site-specific recombination (SSR) system (see RMgm-269, RMgm-747). Removal of (part of) the FRTed ORF of Atg7-cKO has been achieved by  transmission of the mutant through mosquitoes, thereby activating expression of the FlpL recombinase in sporozoites that resulted in the excision of the ORF of Atg7 which was flanked by FRT sequences.

Published in: bioRxiv preprint doi: https://doi.org/10.1101/2023.08.16.553492

Protein (function)
Autophagy-related E1-like enzyme Atg7.
Atg8, a marker of active autophagy in yeast and mammals, is a small ubiquitin-like molecule, and its conjugation with phosphatidyl ethanolamine (PE) on the autophagosome membrane is essential for cargo selection, membrane tethering, hemifusion, expansion, and closure of autophagosomes. In apicomplexan parasites, Atg8 is conserved along with the intermediate genes required for its conjugation with PE and is specifically localized on the apicoplast membrane. The discrete localization of Atg8 on the apicoplast membrane throughout the parasite life cycle must have a distinct role from its role in autophagy.
In this study evidence is presented for the role of Atg7 in Atg8 conjugation, clearance of micronemes, organelle biogenesis, and expansion of parasites during liver stage development

Phenotype
Normal development of Atg7-cKO sporozoites.
All  mice inoculated with wildtype sporozoites became patent on day 3 p.i., whereas parasites lacking Atg7 (Atg7cKO) failed to initiate blood-stage infection.
Comparable parasite burden in livers in mice infected with Atg7 cKO and wildtype sporozoites until 38 hours post infection (hpi), which which was decreased in late time point samples harvested at 55 hpi. In culture Atg7 cKO sporozoites invaded hepatocytes normally. Immunofluorescence analysis of exo-erythrocytic forms (EEFs) with Hsp70 and UIS4 antibodies followed by quantification revealed normal development until 24 hpi. However, EEFs harvested at 40, 55 and 64 hpi showed arrested growth and a reduction in size and number. A strong defect in nuclear division in Atg7 cKO parasites.


Additional information
To check the excision efficiency of the Atg7 gene in sporozoites, genotyping was performed, which revealed successful excision of the flirted Atg7 locus transfected in the TRAP/FlpL line. These results suggest that Atg7 is not required for the progression of sporozoites from the midgut to the salivary gland.

In the paper evidence is presented that:
- Atg7 cKO parasites failed to mature into hepatic merozoites due to impaired organelle biogenesis
Extensive branching of the apicoplast and ER in TRAP/FlpL parasites, while this branching was lost in the Atg7 cKO parasites.
- Atg7-mediated conjugation of Atg8 is required for biogenesis of the apicoplast.
- Atg7 is essential for the exocytosis of unnecessary superfluous organelles during liver stage development.

Other mutants


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0922200
Gene Model P. falciparum ortholog PF3D7_1126100
Gene productautophagy-related protein 7, putative
Gene product: Alternative nameAtg7
Details of the genetic modification
Short description of the mutationThe mutant contains a FRTed ORF of the Atg7 locus
Inducable system usedFlp/FRT
Short description of the conditional mutagenesisThe ORF of Atg7 is removed in the sporozoite stage by the Flp/FRT system
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerunknown
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationFor the generation of conditional knockout of PbAtg7, three fragments, F5 (1.03 371 kb), F6 (0.16 kb) and F7 (0.62 kb), were amplified using primers 1325/1326, 1327/1328 and 372 1353/1330, respectively. All three fragments F5, F6, and F7 were sequentially cloned and inserted into a p3’TRAP-flitre-hDHFR plasmid at HindIII/NotI, EcoRV, and SalI/KpnI restriction sites, respectively. For swapping the 3’UTR of the gene with TRAP, 12 bp was added to the F6 fragment for the continuation of 3’UTR function. The cloned plasmid was linearized by restriction digestion with HindIII/KpnI and transfected into P. berghei ANKA TRAP/FlpL purified schizonts
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameFlpL recombinase of yeast (FlpL)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe FlpL coding sequence was flanked by 1.58 kb and 0.55 kb of 5′ and 3′ regulatory sequences of trap, respectively.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1349800
Gene Model P. falciparum ortholog PF3D7_1335900
Gene productthrombospondin-related anonymous protein | sporozoite surface protein 2
Gene product: Alternative nameTRAP; SSP2; SSP-2
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_1349800
Gene productsporozoite surface protein 2 thrombospondin-related anonymous protein
Gene product: Alternative namesporozoite surface protein 2; SSP2; SSP-2
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4